Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1975-03-17
1977-12-20
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, G01N 3300, G21H 502
Patent
active
040642275
ABSTRACT:
An improved, simplified radioimmunoassay method for the in vitro determination of cardiotonic glycosides in unextracted blood serum involves the use of a reagent constituting a buffer solution containing a radioactive hapten for such glycosides. Packaged test kits for use in conveniently carrying out the radioimmunoassay are also provided.
REFERENCES:
patent: 3666854 (1972-05-01), Eisentraut
patent: 3799740 (1974-03-01), Mincey
patent: 3810886 (1974-05-01), Rutner et al.
patent: 3855208 (1974-12-01), Rutner et al.
patent: 3925355 (1975-12-01), Piasio et al.
Lanoxitest .gamma., Wellcome Reagents Ltd., Nov. 1973, pp. 1-6.
Oliver, Jr. et al, The Journal of Clinical Investigation, vol. 47, 1968, pp. 1035-1042.
Sterling et al, Journal of Clinical Endocrinology and Metabolism, vol. 21, Apr. 1961, pp. 456-464.
Brown James L.
Lyle Leo R.
Klostermann R. J.
Mallinckrodt Inc.
Nucker Christine M.
Padgett Benjamin R.
LandOfFree
Radioimmunoassay method for the determination of cardiotonic gly does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radioimmunoassay method for the determination of cardiotonic gly, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radioimmunoassay method for the determination of cardiotonic gly will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-600163